Cash-strapped TorreyPines Divests its Alzheimer’s Disease Developments
By Taskin Ahmed
Pharma Deals Review: Vol 2008 Issue 102 (Table of Contents)
Published: 18 Nov-2008
DOI: 10.3833/pdr.v2008.i102.107 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
In order to raise cash to progress its clinical developments, TorreyPines Therapeutics is disposing its Alzheimer’s developments through two recently signed deals...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS